Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
34 hedge funds and large institutions have $45M invested in Psychemedics Corporation in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 4 closing their positions.
36% more capital invested
Capital invested by funds: $33M → $45M (+$12M)
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
8% less funds holding
Funds holding: 37 → 34 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q1 2016 in Review
34 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2016, worth a combined $45M — up 36% from $33M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PMD and 1 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 12 added.
The largest buyer was Moors & Cabot, adding an estimated $2.17M. The largest seller was Kennedy Capital Management, cutting an estimated $814K.
- 34 institutional investors held Psychemedics Corporation (PMD) as of Q1 2016, down from 37 in Q4 2015.
- Funds reported $45M of Psychemedics Corporation stock for Q1 2016, up 36% quarter-over-quarter.
- 1 fund opened new Psychemedics Corporation positions in Q1 2016 and 4 closed out, a net change of -3 holders.
- The largest Psychemedics Corporation buyer in Q1 2016 was Moors & Cabot, an estimated $2.17M added.
- The largest Psychemedics Corporation seller in Q1 2016 was Kennedy Capital Management, an estimated $814K sold.
Based on aggregated 13F filings for Q1 2016.